1. Fan, Linwei, Guo, Dingfan, Zhu, Chao, Yu, Kuai, Le, Aiping. 2024. LRRC45 accelerates bladder cancer development and ferroptosis inhibition via stabilizing NRF2 by competitively KEAP1 interaction. In Free radical biology & medicine, 226, 29-42. doi:10.1016/j.freeradbiomed.2024.11.001. https://pubmed.ncbi.nlm.nih.gov/39522565/
2. Wang, Qian, Liu, Xin-Yan, Zhang, Xiao-Qi, Liu, Shan-Shan, Lu, Bing. 2024. LRRC45 promotes lung cancer proliferation and progression by enhancing c-MYC, slug, MMP2, and MMP9 expression. In Advances in medical sciences, 69, 451-462. doi:10.1016/j.advms.2024.09.007. https://pubmed.ncbi.nlm.nih.gov/39326735/
3. Radhakrishnan, Periyasamy, Quadri, Neha, Erger, Florian, Upadhyai, Priyanka, Shukla, Anju. 2024. Biallelic Variants in LRRC45 Impair Ciliogenesis and Cause a Severe Neurological Disorder. In Clinical genetics, 107, 311-322. doi:10.1111/cge.14663. https://pubmed.ncbi.nlm.nih.gov/39638757/
4. Bae, Joon Seol, Lee, Ji Won, Yoo, Jung Eun, Song, Yun-Mi, Sung, Ki Woong. 2020. Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children. In Cancer research and treatment, 52, 1251-1261. doi:10.4143/crt.2020.140. https://pubmed.ncbi.nlm.nih.gov/32599975/